Occupations and the Risk of Head and Neck Cancer: A Pooled Analysis of the International Head and Neck Cancer Epidemiology (INHANCE) Consortium.


Journal

Journal of occupational and environmental medicine
ISSN: 1536-5948
Titre abrégé: J Occup Environ Med
Pays: United States
ID NLM: 9504688

Informations de publication

Date de publication:
05 2019
Historique:
entrez: 4 7 2019
pubmed: 4 7 2019
medline: 6 11 2020
Statut: ppublish

Résumé

To investigate the associations between head and neck cancer (HNC) risk and occupations. We harmonized data on occupations in a pooled analysis of 8839 HNC cases and 13,730 controls in International Head and Neck Cancer Epidemiology (INHANCE) consortium. Logistic regression was used to estimate odds ratios (ORs) for associations of occupations and HNC risk. Population attributable fraction (PAF) for occupations was calculated using the formula PEC × (OR - 1)/OR. Trend of increasing HNC risk was found with increasing duration of employment for many occupations, including cooks (OR = 1.36; 95% confidence interval [CI] 1.09 to 1.68), cleaners (OR = 1.38; 95% CI 1.13 to 1.69), painters (OR = 1.82; 95% CI 1.42 to 2.35). The PAF for a priori occupations was 14.5% (95% CI 7.1% to 21.9%) for HNC. We found associations between certain occupations and HNC risks, including for subsites, with a duration-response relationship.

Identifiants

pubmed: 31268937
doi: 10.1097/JOM.0000000000001563
pii: 00043764-201905000-00005
pmc: PMC6613803
mid: NIHMS1521414
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

397-404

Subventions

Organisme : NCI NIH HHS
ID : P01 CA068384
Pays : United States
Organisme : NCI NIH HHS
ID : R13 CA210555
Pays : United States
Organisme : NIDCR NIH HHS
ID : R01 DE013158
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA030022
Pays : United States
Organisme : NCI NIH HHS
ID : K07 CA104231
Pays : United States
Organisme : NCI NIH HHS
ID : R03 CA113157
Pays : United States
Organisme : NIDCR NIH HHS
ID : R03 DE016611
Pays : United States

Références

J Epidemiol Community Health. 1984 Jun;38(2):117-21
pubmed: 6747509
Cancer Epidemiol Biomarkers Prev. 2008 Aug;17(8):1974-81
pubmed: 18708387
IARC Monogr Eval Carcinog Risks Hum. 2006;86:1-294
pubmed: 16906675
J Natl Cancer Inst. 2007 May 16;99(10):777-89
pubmed: 17505073
Cancer Med. 2013 Dec;2(6):978-86
pubmed: 24403272
Occup Environ Med. 1997 Jul;54(7):477-82
pubmed: 9282123
Int J Epidemiol. 2004 Aug;33(4):799-806
pubmed: 15155704
Scand J Work Environ Health. 1996 Oct;22(5):346-52
pubmed: 8923607
Am J Ind Med. 2014 Dec;57(12):1386-97
pubmed: 25351857
Scand J Work Environ Health. 1991 Aug;17(4):248-54
pubmed: 1925436
Scand J Work Environ Health. 2001 Aug;27(4):233-9
pubmed: 11560337
Oncol Rep. 1999 Mar-Apr;6(2):317-20
pubmed: 10022996
BMJ. 2002 Oct 12;325(7368):822-7
pubmed: 12376446
Oral Oncol. 2009 Sep;45(9):743-6
pubmed: 19442571
Anticancer Res. 1998 Nov-Dec;18(6B):4779-86
pubmed: 9891557
Br J Ind Med. 1992 Dec;49(12):837-44
pubmed: 1472441
Cancer Causes Control. 2003 Apr;14(3):203-12
pubmed: 12814199
J Occup Environ Med. 2013 Sep;55(9):1065-73
pubmed: 23969505
Lancet Oncol. 2017 May;18(5):581-582
pubmed: 28408286
Eur Arch Otorhinolaryngol. 2016 Jan;273(1):9-20
pubmed: 25311307
JAMA Oncol. 2017 Apr 01;3(4):524-548
pubmed: 27918777
IARC Monogr Eval Carcinog Risk Chem Hum. 1980;23:1-415
pubmed: 6933135
J Natl Cancer Inst. 2011 Dec 21;103(24):1827-39
pubmed: 22158127
Cancer Causes Control. 2000 Aug;11(7):627-33
pubmed: 10977107
Expert Rev Anticancer Ther. 2008 May;8(5):799-809
pubmed: 18471051
Int J Epidemiol. 2015 Feb;44(1):169-85
pubmed: 25613428
Head Neck. 2018 Dec;40(12):2724-2732
pubmed: 30387891
Cancer Res. 1988 Apr 1;48(7):1960-4
pubmed: 3349470
Br J Ind Med. 1990 Jun;47(6):380-3
pubmed: 2378815
Ann Oncol. 2016 Aug;27(8):1619-25
pubmed: 27234641
IARC Monogr Eval Carcinog Risks Hum. 1990;48:1-278
pubmed: 2374288
IARC Monogr Eval Carcinog Risks Hum. 2012;100(Pt C):11-465
pubmed: 23189751
IARC Monogr Eval Carcinog Risks Hum. 1993;58:1-415
pubmed: 8022054
Stat Med. 1991 Apr;10(4):585-98
pubmed: 2057657
Int J Cancer. 2012 May 15;130(10):2397-406
pubmed: 21671472
Environ Health. 2017 Jul 24;16(1):77
pubmed: 28738894

Auteurs

Prerna Khetan (P)

The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York City, New York (Dr Khetan, Dr Boffetta, Dr Hashim); University of Rennes, National Institute of Health and Medical Research, School of Advanced Studies in Public Health, Institute for Health, Environment and Work Research - Research Unit UMR_S 1085, Pointe-à-Pitre, France (Dr Luce); Cancer and Environment Team, National Institute of Health and Medical Research U1018, Paris-Sud University, Paris-Saclay University, Villejuif, France (Dr Stucker); Cancer and Environment team (CESP), (Inserm) National Institute of Health and Medical Research U1018, Paris-Sud University, Paris-Saclay University, Villejuif, France (Dr Stucker); Federal University of Pelotas, Pelotas (Dr Menezes); University of Sao Paulo, Sao Paulo, Brazil (Dr Wunsch-Filho); Leibniz Institute for Prevention Research and Epidemiology, Bremen Institute for Prevention Research and Social Medicine , Bremen, Germany (Dr Ahrens); School of Medicine, National and Kapodistrian University of Athens, Greece (Dr Lagiou); Oncological Reference Center, Institute of Scientific Characterization and Hospitalization, Aviano, Italy (Dr Serraino); Department of Medical Sciences, University of Turin, Turin (Dr Richiardi); Cancer Registry of Norway, Institute of Population-based Cancer Research, Oslo, Norway (Dr Kjaerheim); School of Medicine, Dentistry, and Nursing, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK (Dr Conway); University of Hong Kong, Hong Kong, China (Dr Thomson); Penn State College of Medicine, Hershey, Pennsylvania (Dr Muscat); National Institute of Public Health, Bucharest, Romania (Dr Mates); University of Heidelberg (Dr Ramroth); National Institute of Health and Medical Research, Sorbonne University, Pierre Louis Institute of Epidemiology and Public Health, Paris, France (Dr Menvielle); Fred Hutchinson Cancer Research Center, Seattle, Washington (Dr Vaughan); Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany (Dr Brenner); Division of Preventive Oncology, German Cancer Research Center and National Center for Tumor Diseases, Heidelberg, Germany (Dr Brenner); German Cancer Consortium, German Cancer Research Center, Heidelberg, Germany Hermann Brenner (Dr Brenner); Division of Public Health, Department of Family & Preventive Medicine and Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah (Dr Lee, Dr Hashibe); Department of Clinical Sciences and Community Health, University of Milan, Milan (Dr La Vecchia), Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH